Related Experiment Video
Updated: Feb 6, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Barriers to Medication Access in Pediatric Oncology in the United States
Michael J Kelly1, Lillian Sung2, David S Dickens3,4
1Division of Pediatric Hematology Oncology, The Floating Hospital for Children at Tufts Medical Center, Boston, MA.
Insights
Barriers to medication access, including prior authorization (PA) requests, frequently delay or alter pediatric cancer treatments. These delays negatively impact patient care and cause significant emotional distress for families.
Area of Science:
- Oncology
- Health Services Research
- Pediatric Care
Background:
- Timely access to medications is critical for effective pediatric oncology treatment.
- Barriers to medication access in pediatric cancer care are not well-documented.
Purpose of the Study:
- To describe the impact of medication access barriers on pediatric oncology treatment.
- To identify common challenges faced by healthcare providers in accessing prescribed medications for pediatric patients.
Main Methods:
- A survey was administered to pediatric oncology healthcare providers at National Cancer Institute Community Oncology Research Program sites.
- The survey collected data on medication acquisition difficulties, prior authorization (PA) requests, insurance denials, and patient copays in calendar year 2016.
Main Results:
- Prior authorization (PA) requests were the most frequent issue, causing deviations or delays in treatment for at least 61% of respondents.
- Half of the respondents believed PA-induced delays negatively impacted patient care.
- Two-thirds of respondents reported that therapy delays due to medication access barriers caused psychological or emotional distress for patients and families.
Conclusions:
- Barriers to medication access, particularly PA requests, are prevalent in pediatric oncology.
- These barriers can lead to suboptimal care and significant emotional burden for pediatric cancer patients and their families.
Abstract:
Timely medication access in pediatric oncology is important; yet barriers are poorly described. We surveyed pediatric oncology health care providers at National Cancer Institute Community Oncology Research Program sites on their experience with the impact of drug acquisition difficulties, prior authorization (PA) requests, insurance denials, and patient copays leading to deviations or delays from prescribed treatment for their pediatric/adolescent/young adult patients in calendar year 2016. PA requests, the most frequently cited issue, created a deviation or delay from planned chemotherapy and supportive care treatment in at least 61% of respondents. Half of the respondents believed that PA-induced delays had a negative impact on care. Two-thirds of respondents felt that delays in starting therapy due to barriers in medication access created psychologic or emotional distress for the patient or family. Pediatric cancer patients may be receiving inferior care as a result of barriers to medication access.
Related Concept Videos
Measurement: Standard Units
Measurement: Derived Units
Inhaled Medications
Units of Measurement
There are various well-known historical measurement systems, such as the Babylonian system, the Roman system, the Egyptian system, the Olympian system, the British system, and the Indus...
International System of Units
Prefixes are used to define both larger and smaller quantities in the SI system. For example, milli, micro, and nano define smaller quantities, while kilo, mega, and giga are used to define...
Motor Units

